Preclinical Reversal of Atherosclerosis by FDA-Approved...

Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory “Prodrug”

Mendelsohn, Andrew R., Larrick, James W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Rejuvenation Research
DOI:
10.1089/rej.2016.1849
Date:
June, 2016
File:
PDF, 75 KB
english, 2016
Conversion to is in progress
Conversion to is failed